FDA on the draft environmental assessment and preliminary finding of no significant impact concerning investigational use of Oxitec OX513A mosquitoes

Written By Michael Leary

May 12, 2016. CLA submits comments to the FDA on the draft environmental assessment and preliminary finding of no significant impact concerning investigational use of Oxitec OX513A mosquitoes
Read the comments.

Michael Leary
Previous

Memorandum to open docket for meeting minutes, documents, and proposals related to integrated approaches to testing and assessment
Next

FDA on the use of the term “natural” in the labeling of human food products